549 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (updated)
Date of authorisation: 08/05/2017,
, 
, 
, Revision: 7, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Bosulif (updated)
Date of authorisation: 26/03/2013,, 
, Revision: 19, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Raxone (updated)
Date of authorisation: 08/09/2015,, , , Revision: 5, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Myozyme (updated)
Date of authorisation: 28/03/2006,, Revision: 16, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Mepsevii (updated)
Date of authorisation: 23/08/2018,, , , Revision: 3, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Xermelo (updated)
Date of authorisation: 17/09/2017,, , Revision: 8, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Strensiq (updated)
Date of authorisation: 28/08/2015,, , , Revision: 10, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Farydak (updated)
Date of authorisation: 28/08/2015,, , Revision: 7, Authorised, Last updated: 02/12/2019
-
List item
Human medicine European public assessment report (EPAR): Translarna (updated)
Date of authorisation: 31/07/2014,, , , Revision: 13, Authorised, Last updated: 02/12/2019
-
List item
Human medicine European public assessment report (EPAR): Vyndaqel (updated)
Date of authorisation: 16/11/2011,, , , Revision: 15, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Somavert (updated)
Date of authorisation: 12/11/2002,, Revision: 21, Authorised, Last updated: 28/11/2019
-
List item
Human medicine European public assessment report (EPAR): Crysvita (updated)
Date of authorisation: 19/02/2018,, , , Revision: 2, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Atriance (updated)
Date of authorisation: 22/08/2007,, , , Revision: 21, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Elaprase (updated)
Date of authorisation: 08/01/2007,, , , Revision: 19, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Revatio (updated)
Date of authorisation: 28/10/2005,, Revision: 38, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Scenesse (updated)
Date of authorisation: 22/12/2014,, , , Revision: 5, Authorised, Last updated: 26/11/2019
-
List item
Human medicine European public assessment report (EPAR): Trisenox (updated)
Date of authorisation: 05/03/2002,, Revision: 27, Authorised, Last updated: 26/11/2019
-
List item
Human medicine European public assessment report (EPAR): Exjade (updated)
Date of authorisation: 28/08/2006,, , Revision: 43, Authorised, Last updated: 25/11/2019
-
List item
Human medicine European public assessment report (EPAR): Besponsa (updated)
Date of authorisation: 28/06/2017,, , Revision: 5, Authorised, Last updated: 25/11/2019
-
List item
Human medicine European public assessment report (EPAR): Defitelio (updated)
Date of authorisation: 18/10/2013,, , , Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
Date of authorisation: 14/10/2016,, Revision: 4, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Nexavar (updated)
Date of authorisation: 19/07/2006,, Revision: 28, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos) (updated)
Date of authorisation: 23/08/2018,, Revision: 2, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Esbriet
Date of authorisation: 27/02/2011,, Revision: 24, Authorised, Last updated: 15/11/2019
-
List item
Human medicine European public assessment report (EPAR): Symkevi
Date of authorisation: 31/10/2018,, , Revision: 3, Authorised, Last updated: 14/11/2019